e-learning
resources
Virtual 2021
07.09.2021
Biomarkers to phenotype COPD: prediction of exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fat-Free Mass Index and functional limitation in COPD
S. Mariam (Sfax, Tunisia), K. Khouloud (Sfax, Tunisia), H. Asma (Sfax, Tunisia), C. Sahar (Sfax, Tunisia), M. Kaouthar (Sfax, Tunisia)
Source:
Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Session:
Biomarkers to phenotype COPD: prediction of exacerbations
Session type:
E-poster
Number:
3424
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mariam (Sfax, Tunisia), K. Khouloud (Sfax, Tunisia), H. Asma (Sfax, Tunisia), C. Sahar (Sfax, Tunisia), M. Kaouthar (Sfax, Tunisia). Fat-Free Mass Index and functional limitation in COPD. 3424
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Association between Frailty Index and BODE index with lung function and mortality in COPD
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Body Mass Index (BMI) in a relation to asthma, high fiver and eczema and their current symptoms
Source: Eur Respir J 2003; 22: Suppl. 45, 498s
Year: 2003
Exercise-induced bronchospasm in asthmatic Children. FENO and Body Mass Index relationship
Source: Virtual Congress 2020 – Paediatric asthma
Year: 2020
Multidimensional system for assessment of COPD patients. Comparison with BODE index
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Comparison of Body Fat Composition and Body Mass Index as a risk factor for severity of small airway obstruction in school-aged children in Korea
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Body mass index and asthma severity
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008
Body mass index in COPD: what relationship?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Comparison of the measurement of LCI and FRC by the NDD EasyOne ProLAB and mass spectrometry (MS)
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Body mass index and asthma severity in children
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
COPD Assessment Test responsiveness during acute exacerbations recovery: the role of body mass index
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index
Source: Eur Respir J 2014; 43: 397-408
Year: 2013
Dyspnea and mortality in elderly: the role of the body mass index (BMI)
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Development and validation of a new comorbidity index for COPD
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Prognostic value of the Charlson Comorbidity Index in patient with COPD
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Assessment of total muscle mass in COPD patients
Source: Annual Congress 2010 - Rehabilitation: more than just exercise
Year: 2010
Relationship between London chest daily living activity scale and i-BODE index in COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Body mass index and quality of life in patients with asthma
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Can we assess COPD comorbidities by BODE index?
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept